Cmv Infection

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2023-10-10
Clinical Trial Update: Multivirus-specific T Cells in the Treatment of Refractory CMV and/or EBV Infection After Allo-HSCT [Phase 1, Phase 2]
A phase 1/2 clinical trial evaluating multivirus-specific T cells for refractory CMV and/or EBV infection after allo-HSCT.
CLINICAL_TRIALS trial_result · 2023-09-01
Clinical Trial Update: Letermovir for the Prevention of CMV Infection in HSCT Recipients Based on the Outcome of mNGS [Phase 2]
Phase 2 clinical trial updating the use of letermovir for prevention of CMV infection in hematopoietic stem cell transplant recipients, eval…
CLINICAL_TRIALS trial_result · 2020-12-23
Clinical Trial Update: Multicenter Clinical Trial to Evaluate the Efficacy of a Preventive Strategy Against CMV Infection in Heart Transplant Patients, Based on the Specific T Cells Response [Phase 4]
Phase 4 multicenter trial evaluating a preventive CMV infection strategy in heart transplant patients, focusing on T cell–specific responses…
CLINICAL_TRIALS trial_result · 2020-03-10
Clinical Trial Update: Preemptive Therapy With CMV-specific T Cells Infusion to Prevent Refractory CMV Infection Post Transplantation [Phase 1, Phase 2]
A Phase 1/2 trial evaluating preemptive therapy with CMV-specific T cell infusions to prevent refractory CMV infection after transplantation…
CLINICAL_TRIALS trial_result · 2019-09-19
Clinical Trial Update: Antigen-specific Cytotoxic T Cells in the Treatment of Opportunistic Infections [Phase 1, Phase 2]
A phase 1/2 clinical trial evaluating antigen-specific cytotoxic T cells for treating opportunistic infections including EBV, CMV, adenoviru…
Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
CLINICAL_TRIALS trial_result · 2018-10-03
Clinical Trial Update: Prospective, Randomized Study for Predicting Human Cytomegalovirus (hCMV) Infection Based on Baseline hCMV Specific T-cell Response in Kidney Transplant [Phase 4]
A Phase 4 randomized trial evaluating whether baseline CMV-specific T-cell responses can predict CMV infection in kidney transplant recipien…